Jagsonpal Pharmaceuticals Ltd Share Price
As on 13 June 2026 at 01:10 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-0.22%
Over 6 Months
4.59%
Over 1 Year
-11.97%
Over 3 Years
42.03%
Jagsonpal Pharmaceuticals Ltd Summary
Close ₹209.63
Open ₹205
High ₹211.40
Low ₹205
Volume 1,03,566
Net Turnover (in Cr) ₹2.15
52Wk High ₹301.65
52Wk Low ₹155
52Wk High / Low
155
301.65
Jagsonpal Pharmaceuticals Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹1,380.11
EPS (TTM) 6.78
Book Value (BV) 41.91
Div. Yield 1.94 %
P/E (TTM) 32.03
Price/Book Value 5
Delivery % 43.29 %
Face Value 2
Key Ratios
PE Ratio 25.89
PB Ratio 5.99
EV to Sales 4.89
PEG Ratio -13.75
ROA 22.07
ROE 18.58
Debt-Equity 0.04
Net Profit Margin 14.77
Operating Profit Margin 22.05
Jagsonpal Pharmaceuticals Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 276.91 | 217.98 | 242.45 | 221.01 | 192.34 |
| Total Expenses | 226.73 | 188.11 | 204.18 | 194.37 | 170.47 |
| Profit Before Tax | 69.86 | 29.87 | 34.81 | 26.64 | 21.87 |
| Profit After Tax | 55.36 | 22.46 | 26.72 | 18.86 | 17.06 |
| Operating Profit After Depreciation | 51.13 | 30.68 | 38.68 | 26.93 | 22.39 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 94.45 | 9.30 | 24.28 | 22.60 | 25.72 |
| Total Non Current Assets | 117.07 | 20.30 | 30.39 | 55.14 | 43.73 |
| Total Current Assets | 161.19 | 196.78 | 164.56 | 109.08 | 120.48 |
| Total Assets | 278.26 | 217.08 | 194.95 | 164.22 | 164.20 |
| Total Shareholder's Fund | 239.95 | 187.40 | 158.89 | 132.76 | 121.93 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 55.30 | 35.17 | 46.66 | 6.91 | 28.22 |
| Net Cash Used In Investing Activities | -45.15 | -24.55 | -57.67 | -25.78 | -2.26 |
| Net Cash Used In Financing Activities | -11.70 | -8.91 | -0.46 | -17.55 | -6.83 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 64.20 | 72.95 | 74.47 | 75.61 | 58.56 |
| Total Expenses | 53.04 | 56.67 | 58.03 | 61.40 | 49.84 |
| Profit Before Tax | 11.76 | 14.53 | 16.81 | 14.44 | 8.71 |
| Profit After Tax | 8.76 | 10.95 | 12.57 | 10.80 | 6.58 |
| Operating Profit after Depreciation | 14.33 | 19.26 | 19.47 | 17.04 | 11.49 |
Jagsonpal Pharmaceuticals Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 205.95
S2 202.28
S3 199.55
Pivot 208.68
R1 212.35
R2 215.08
R3 218.75
Moving Average
20 SMA 204.42
50 SMA 201.41
100 SMA 187.98
200 SMA 202.56
Jagsonpal Pharmaceuticals Ltd Corporate Actions
Jagsonpal Pharmaceuticals Ltd
₹2.5/Share
Announcement Date 12 Sep 2025
Record Date 12 Sep 2025
Div Yield 125%
Jagsonpal Pharmaceuticals Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Jagsonpal Pharmaceuticals Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.03% |
Jagsonpal Pharmaceuticals Ltd News
Jagsonpal Pharmaceuticals allots 2.96 lakh equity shares under ESOP
04 Jun 2026, 06:45 pm
Jagsonpal Pharmaceuticals allots 1.93 lakh equity shares under ESOP
28 Apr 2026, 11:36 am
Board of Jagsonpal Pharmaceuticals recommends final dividend
Of Rs 4 per share
28 Apr 2026, 11:22 am
Jagsonpal Pharmaceuticals schedules board meeting
On 27 April 2026
21 Apr 2026, 10:36 am
Jagsonpal Pharmaceuticals allots 1.76 lakh equity shares under ESOP
13 Apr 2026, 05:06 pm
Jagsonpal Pharmaceuticals Ltd Stock Analysis
- Annual revenue for Jagsonpal Pharmaceuticals Ltd increased by 27.03% to ₹276.91 crore in FY 2025 from ₹217.98 crore in FY 2024.
- Annual Net Profit for Jagsonpal Pharmaceuticals Ltd increased by 146.45% to ₹55.36 crore in FY 2025 from ₹22.46 crore in FY 2024.
- Promoter Shareholding in Jagsonpal Pharmaceuticals Ltd increased by 2.17% in the most recent quarter, from 67.89% in March 2026 to 69.36% in June 2026.
- Jagsonpal Pharmaceuticals Ltd delivered a 1-year return of -11.97% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Jagsonpal Pharmaceuticals Ltd share price moved up by 2.68% from its previous close of INR ₹209.63. The latest Jagsonpal Pharmaceuticals Ltd share price is INR ₹215.25.
- Jagsonpal Pharmaceuticals Ltd share price today has been at a low of 210.93 and a high of 218. Over the past 52 weeks, the Jagsonpal Pharmaceuticals Ltd share price has seen a low of 155 and a high of 301.65.
FAQ’s
What is the share price of Jagsonpal Pharmaceuticals Ltd today?
Jagsonpal Pharmaceuticals Ltd share price as on 12 Jun 2026 is ₹ 215.25
What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?
The market cap of Jagsonpal Pharmaceuticals Ltd stock is ₹1,380.11 Cr.
What is the PE Ratio of Jagsonpal Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Jagsonpal Pharmaceuticals Ltd is 25.89
What is the PB Ratio of Jagsonpal Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Jagsonpal Pharmaceuticals Ltd is 5.99
What is the 52 week high of Jagsonpal Pharmaceuticals Ltd Share Price?
The 52 week high of Jagsonpal Pharmaceuticals Ltd share price stands at ₹301.65
What is the 52 week low of Jagsonpal Pharmaceuticals Ltd Share Price?
The 52 week low of Jagsonpal Pharmaceuticals Ltd share price stands at ₹155
How can I buy shares of Jagsonpal Pharmaceuticals Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Jagsonpal Pharmaceuticals Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
